Loading organizations...
Stonepine Capital Management is an investment management firm specializing in life sciences. The company provides financial advisory services, including private investments in public equity, secondary offerings, and mergers and acquisitions. It applies deep sector expertise to identify and foster growth within biotechnology and commercial-stage life science companies.
Jon Plexico founded Stonepine Capital Management around fourteen years ago, drawing on over three decades of life science experience. Plexico's background includes leadership in healthcare corporate finance at Merriman Curhan Ford & Co., co-founded Venture Ready Partners, a life science advisory firm. He also played a key role in Chemdex during its IPO.
The firm serves biotechnology and commercial-stage life science companies seeking strategic investments and growth capital. Stonepine Capital Management's vision is to accelerate innovation by thoroughly evaluating and funding promising ventures. It aims to be a financial and strategic partner in the life science sector.
Stonepine Capital Management has 1 tracked investment across 1 company. The latest tracked deal is $13.0M Other Equity in Tobira Therapeutics in March 2015.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 9, 2015 | Tobira Therapeutics | $13.0M Other Equity | — | Abingworth, BVF Partners |